Table of Contents
Perspectives
| Oxidative stress in tumor microenvironment——Its role in angiogenesis | |
| Armando ROJAS, Raul SILVA, Hector FIGUEROA, Miguel A MORALES | 297-305 |
Basic Research
| Construction and expression of eukaryotic expression vectors of full-length, amino-terminus and carboxyl-terminus Raf gene | |
| Zhuomin WANG, Jun CHEN, Haisu WAN, Hongyu LIU, Wen ZHU, Wen XIAO, Yu FAN, Yongwen LI, Liya SUN, Qinghua ZHOU | 306-310 |
| Effect of 20(R) ginsenoside Rg3 on protein expression of lung cancer cell line | |
| Ning AN, Wen ZHU, Zhihua FENG, Sujuan YE, Chuanjiang YU, Chunji CAI | 311-320 |
| The study of the tumorigenicity and metastasis ability in human lung cancer cell line L9981 using in vivo imaging | |
| Yuanrong REN, Jun CHEN, Hongyu LIU, Huiqin YAN, Yuli WANG, Chengfei LIU, Qinghua ZHOU | 321-326 |
| Genome-wide detection of loss of heterozygosity and copy number variation in a human lung large cell carcinoma cell line by affymetrix single-nucleotide polymorphism array 500K | |
| Bin HU, Jun CHEN, Hongyu LIU, Heng WU, Zhihao WU, Yuli WANG, Yun BAI, Ying LI, Qinghua ZHOU | 327-332 |
| Analysis of the relationship between the response after the First-line chemotherapy and the survival in the advanced non-small cell lung cancer | |
| Liping LIN, Xiaojuan XIANG, He HUANG, Hongyun ZHAO, Yang ZHANG, Jingxun WU, Yuanyuan ZHAO, Xuan WU, Li ZHANG | 333-338 |
| Effects of paclitaxel and gefitinib on the proliferation and cell cycle of human lung adenocarcinoma cell SPC-A1 | |
| Gang Jia, Weimin ZHANG, Juan ZHOU, Zhixia ZHU | 339-344 |
| The role of autophagy in human lung cancer cell line A549 induced by Vinorelbine | |
| Xiao FU, Yongcheng PAN, Jianjun WANG, Quan LIU, Guanghai YANG, Jinsong LI | 345-348 |
| The mechanism and influence on the biological behavior of human high-metastatic large cell lung cancer cell lines with transfection of nm23-H1 gene | |
| Qiang NIE, Wen ZHU, Lunxu LIU, Junke FU, Dingbiao LI, Yin LI, Jun CHEN, Hongyu LIU, Qinghua ZHOU | 349-353 |
| Selenium compounds induce ROS in human high-metastatic large cell lung cancer cell line L9981 | |
| Chengfei LIU, Jun CHEN, Zhihao WU, Ying LI, Yu ZHU, Yuanrong REN, Qinghua ZHOU | 354-358 |
| Construction and expression of recombinant prokaryotic vector PGEX-4T-1-BC006151 correlated with multidrug resistant of lung adenocarcinoma | |
| Xuejun Li, Heping YANG, Xiangdong ZHOU | 359-362 |
| The variation of intracellular distribution and translocation of the protein kinase C? among human lung cancer cell line with different metastasis potential | |
| Qiang Nie, Wen ZHU, Lunxu LIU, Junke FU, Dingbiao LI, Yin LI, Jun CHEN, Zhihao WU, Qinghua ZHOU | 363-367 |
| Effects of apoptosis protein XIAP inhibitor on the apoptosis and sensitivity of chemotherapy in A549 cell | |
| Fuhui CHEN, Hongyan QU, Guangjie SUI | 368-372 |
| Development and clinical application of frozen tissue microarray in lung cancer diagnosis | |
| Haiyan ZHENG, Xinyun WANG, Aixiang WANG, Ting LIU, Congzhong ZHU, Ling YUAN, Min ZHAO, Xi HUANG | 373-376 |
Clinical Research
| Expression and its clinical significance of HMGA2 in the patients with non-small cell lung cancer | |
| Ying WU, Yong SONG, Hongbing LIU | 377-381 |
| Prognostic predictors for non-small cell lung cancer patients with brain metastasis after radiotherapy | |
| Qiuhong FAN, Chunhua SUN, Ye TIAN | 382-385 |
| Analysis of bronchoscopy characteristics for 729 female patients with lung cancer | |
| Min LI, Chengping HU, Hongzhong YANG, Huaping YANG, Sujie QU | 386-390 |
| Expression and clinical significance of RhoC and RhoGDIa in non-small cell lung cancer | |
| Yuchen HAN, Yanni WU, Shuang GAO, Yuexin XU, Zhongyan GUAN, Xuebin QIU, Enhua WANG | 391-397 |
| Preoperative induction chemotherapy for resectable stage ?A non-small-cell lung cancer: a meta-analysis of 13 double-blind, randomized clinical trials | |
| Yun DAI, Baohui HAN, Jie SHEN, Dajiang QI, Liyan JIANG, Jianqing GU, Tianqing CHU, Yu DONG, Hui SHI | 398-405 |
| The characteristics of lung cancer cases in 1996-2005 in Nanjing, China | |
| Yi ZENG, Jie LIANG, Hongbing SHEN | 406-409 |
| The clinical analysis of 469 pulmonary carcinomatous cases diagnosed by bronchoscopy under the age of 40 | |
| Min SONG, Chengping HU, Kui XIAO | 410-413 |
| Clinical verification of a mathematical model for prediction of brain metastases in patients with locally advanced non-small cell lung cancer | |
| Binbin ZHANG, Siyu WANG, Wei QU, Yongbin LIN, Hua YANG, Haibo SUN | 414-419 |
| Expression and clinical significance of matrix metalloproteinase-26 in non-small cell lung cancer | |
| Yang ZHANG, Cai LI, Xuexun FANG, Meihua SUN | 420-424 |
| A phase II clinical trial of celecoxib combined with platinum-based chemotherapy in the treatment of patients with advanced NSCLC as first-line treatment | |
| Zhijie WANG, Jianchun DUAN, Qingzhi GUO, Zhigang WEI, Weicheng XUE, Meina WU, Jun ZHAO, Lu YANG, Tongtong AN, Xuyi LIU, Jie WANG | 425-430 |
Brief Report
| Maintenance chemotherapy in 43 patients with advanced non-small cell lung cancer: a retrospective study | |
| Zhenqian LIU, Wei CHEN, Huasong FENG | 431-434 |
| Clinical observation of Alimta monotherapy in treatment of advanced non-small cell lung cancer | |
| Haiyan Wang, Tao QU, Fenglian QU | 435-437 |
Clinical Experience
| A comparative clinical study of weekly regimen of docetaxel compared with that of 3-weekly regimen in the treatment of patients with advanced non-small cell lung cancer | |
| Hongjian XUE, Rui MENG | 438-440 |
| The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy | |
| Yanzhi CHEN, Lijun DI, Shulan ZHANG, Maosen CHEN, Hong SUN, Fei GAO, Ying ZHANG, Pingping LI | 441-444 |
| Less than 3 cm in diameter peripheral squamous cell lung cancer-clinical analysis | |
| Yong CUI, Hao LI, Changjin LIN, Min GONG, Tianyou WANG | 445-446 |
| Clinical analysis of surgical treatment results in 13 patients with primary trachea tumor | |
| Feng Shao, Dongsheng XU, Wei ZOU, Rusong YANG, Keping WANG, Feng LIU, Guodong MA, Hui CAO | 447-448 |
Minireview
| Advances of RAF and lung cancer | |
| Zhuomin WANG, Jun CHEN, Qinghua ZHOU | 449-456 |
| Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer | |
| Xike LU | 457-461 |
| Advances in detection methods for EGFR gene mutation of lung cancer | |
| Shuidong FENG, Hongzhuan TAN | 462-464 |
| Roles of novel antiangiogenetic agents in non-small cell lung cancer | |
| Zhiqiang GAO, Baohui HAN | 465-469 |
| Expression and functions of BAG-1 protein in human cancer cells | |
| Weiqiang WANG, Jun CHEN | 470-472 |
| Present status and advances in lung cancer stem cells | |
| Yong LI, Zhiping WU, Xicai WANG | 473-476 |
